117 related articles for article (PubMed ID: 15567486)
21. Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer's disease.
Barrachina M; Maes T; Buesa C; Ferrer I
Neuropathol Appl Neurobiol; 2006 Oct; 32(5):505-16. PubMed ID: 16972884
[TBL] [Abstract][Full Text] [Related]
22. Interstitial cells subjacent to the entorhinal region expressing somatostatin-28 immunoreactivity are susceptible to development of Alzheimer's disease-related cytoskeletal changes.
van de Nes JA; Sandmann-Keil D; Braak H
Acta Neuropathol; 2002 Oct; 104(4):351-6. PubMed ID: 12200620
[TBL] [Abstract][Full Text] [Related]
23. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.
Buerger K; Ewers M; Pirttilä T; Zinkowski R; Alafuzoff I; Teipel SJ; DeBernardis J; Kerkman D; McCulloch C; Soininen H; Hampel H
Brain; 2006 Nov; 129(Pt 11):3035-41. PubMed ID: 17012293
[TBL] [Abstract][Full Text] [Related]
24. Alterations of heterogeneous nuclear RNP A2 and B1 in the hippocampus of the rat after perforant pathway lesion.
Ishikawa M; Mizukami K; Iwakiri M; Hidaka S; Kamma H; Asada T
Acta Neuropathol; 2004 Feb; 107(2):144-8. PubMed ID: 14608468
[TBL] [Abstract][Full Text] [Related]
25. Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway?
Lee HG; Ueda M; Zhu X; Perry G; Smith MA
J Neurosci Res; 2006 Dec; 84(8):1856-61. PubMed ID: 16998902
[TBL] [Abstract][Full Text] [Related]
26. Alzheimer's disease: intraneuronal alterations precede insoluble amyloid-beta formation.
Braak H; Del Tredici K
Neurobiol Aging; 2004 Jul; 25(6):713-8; discussion 743-6. PubMed ID: 15165692
[No Abstract] [Full Text] [Related]
27. Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain.
Smith JL; Xiong S; Markesbery WR; Lovell MA
Neuroscience; 2006 Jul; 140(3):879-88. PubMed ID: 16580781
[TBL] [Abstract][Full Text] [Related]
28. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY
Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017
[TBL] [Abstract][Full Text] [Related]
29. Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients.
van de Nes JA; Konermann S; Nafe R; Swaab DF
Acta Neuropathol; 2006 Feb; 111(2):126-38. PubMed ID: 16456666
[TBL] [Abstract][Full Text] [Related]
30. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
31. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study.
Good PF; Perl DP; Bierer LM; Schmeidler J
Ann Neurol; 1992 Mar; 31(3):286-92. PubMed ID: 1637136
[TBL] [Abstract][Full Text] [Related]
32. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease.
Gouras GK; Almeida CG; Takahashi RH
Neurobiol Aging; 2005 Oct; 26(9):1235-44. PubMed ID: 16023263
[TBL] [Abstract][Full Text] [Related]
33. Cellular expression of alpha7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease--a stereological approach.
Banerjee C; Nyengaard JR; Wevers A; de Vos RA; Jansen Steur EN; Lindstrom J; Pilz K; Nowacki S; Bloch W; Schröder H
Neurobiol Dis; 2000 Dec; 7(6 Pt B):666-72. PubMed ID: 11114264
[TBL] [Abstract][Full Text] [Related]
34. Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains.
Zhou XW; Li X; Bjorkdahl C; Sjogren MJ; Alafuzoff I; Soininen H; Grundke-Iqbal I; Iqbal K; Winblad B; Pei JJ
Neurobiol Dis; 2006 Jun; 22(3):657-68. PubMed ID: 16513361
[TBL] [Abstract][Full Text] [Related]
35. No difference in expression of apoptosis-related proteins and apoptotic morphology in control, pathologically aged and Alzheimer's disease cases.
Woodhouse A; Dickson TC; West AK; McLean CA; Vickers JC
Neurobiol Dis; 2006 May; 22(2):323-33. PubMed ID: 16406795
[TBL] [Abstract][Full Text] [Related]
36. Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease.
Shepherd CE; Thiel E; McCann H; Halliday GM
Neurobiol Dis; 2001 Feb; 8(1):136-46. PubMed ID: 11162247
[TBL] [Abstract][Full Text] [Related]
37. Transneuronally altered dendritic processing of tangle-free neurons in Alzheimer's disease.
Ohm TG; Münch S; Schönheit B; Zarski R; Nitsch R
Acta Neuropathol; 2002 May; 103(5):437-43. PubMed ID: 11935258
[TBL] [Abstract][Full Text] [Related]
38. Enhanced expression of 14-3-3 proteins in reactive astrocytes in Creutzfeldt-Jakob disease brains.
Kawamoto Y; Akiguchi I; Jarius C; Budka H
Acta Neuropathol; 2004 Oct; 108(4):302-8. PubMed ID: 15235801
[TBL] [Abstract][Full Text] [Related]
39. Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease.
Grudzien A; Shaw P; Weintraub S; Bigio E; Mash DC; Mesulam MM
Neurobiol Aging; 2007 Mar; 28(3):327-35. PubMed ID: 16574280
[TBL] [Abstract][Full Text] [Related]
40. Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons.
Chalmers KA; Love S
J Neuropathol Exp Neurol; 2007 Feb; 66(2):158-67. PubMed ID: 17279001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
